Correlation Between Takeda Pharmaceutical and Ayurcann Holdings
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and Ayurcann Holdings at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and Ayurcann Holdings into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and Ayurcann Holdings Corp, you can compare the effects of market volatilities on Takeda Pharmaceutical and Ayurcann Holdings and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of Ayurcann Holdings. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and Ayurcann Holdings.
Diversification Opportunities for Takeda Pharmaceutical and Ayurcann Holdings
-0.44 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Takeda and Ayurcann is -0.44. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and Ayurcann Holdings Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayurcann Holdings Corp and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with Ayurcann Holdings. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayurcann Holdings Corp has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and Ayurcann Holdings go up and down completely randomly.
Pair Corralation between Takeda Pharmaceutical and Ayurcann Holdings
Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to under-perform the Ayurcann Holdings. But the stock apears to be less risky and, when comparing its historical volatility, Takeda Pharmaceutical Co is 18.15 times less risky than Ayurcann Holdings. The stock trades about -0.02 of its potential returns per unit of risk. The Ayurcann Holdings Corp is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 2.36 in Ayurcann Holdings Corp on August 25, 2024 and sell it today you would lose (0.16) from holding Ayurcann Holdings Corp or give up 6.78% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Takeda Pharmaceutical Co vs. Ayurcann Holdings Corp
Performance |
| Timeline |
| Takeda Pharmaceutical |
| Ayurcann Holdings Corp |
Takeda Pharmaceutical and Ayurcann Holdings Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Takeda Pharmaceutical and Ayurcann Holdings
The main advantage of trading using opposite Takeda Pharmaceutical and Ayurcann Holdings positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, Ayurcann Holdings can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayurcann Holdings will offset losses from the drop in Ayurcann Holdings' long position.| Takeda Pharmaceutical vs. Viatris | Takeda Pharmaceutical vs. Elanco Animal Health | Takeda Pharmaceutical vs. Zoetis Inc | Takeda Pharmaceutical vs. Emergent Biosolutions |
| Ayurcann Holdings vs. Green Cures Botanical | Ayurcann Holdings vs. Galexxy Holdings | Ayurcann Holdings vs. Indoor Harvest Corp | Ayurcann Holdings vs. Speakeasy Cannabis Club |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets |